tiprankstipranks
Trending News
More News >

Advanced Enzyme Technologies Reports Financial Results for Q3 and Nine Months Ending December 2024

Story Highlights
  • Advanced Enzyme Technologies focuses on enzyme-based solutions for biotech and healthcare.
  • The company submitted its financial results for Q3 and nine months, adhering to SEBI regulations.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.

Advanced Enzyme Technologies Ltd ( (IN:ADVENZYMES) ) has shared an update.

Advanced Enzyme Technologies Ltd has submitted its integrated financial results for the quarter and nine months ending December 31, 2024. This submission, in compliance with SEBI regulations, includes unaudited consolidated financial results reviewed by independent auditors. The document outlines the performance of the holding company and its subsidiaries, reflecting the company’s ongoing adherence to regulatory standards and commitment to transparency in reporting.

More about Advanced Enzyme Technologies Ltd

Advanced Enzyme Technologies Ltd operates in the enzyme technology sector, focusing on the development and production of enzyme-based solutions for various industries. The company provides products that cater to the biotechnology and healthcare sectors, emphasizing innovations in enzyme applications.

YTD Price Performance: -5.37%

Average Trading Volume: 20,942

Current Market Cap: 37.14B INR

For detailed information about ADVENZYMES stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App